MENU
+Compare
COO
Stock ticker: NASDAQ
AS OF
Feb 3, 04:59 PM (EDT)
Price
$79.33
Change
+$9.58 (+13.73%)
Capitalization
15.81B

COO Cooper Companies (The) Forecast, Technical & Fundamental Analysis

CooperCompanies is one of the largest eyecare companies in the US... Show more

COO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for COO with price predictions
Feb 02, 2026

COO in downward trend: price may decline as a result of having broken its higher Bollinger Band on January 06, 2026

COO broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COO as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for COO turned negative on December 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 244 cases where COO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.918) is normal, around the industry mean (11.444). P/E Ratio (43.128) is within average values for comparable stocks, (149.532). Projected Growth (PEG Ratio) (2.103) is also within normal values, averaging (2.462). COO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (3.942) is also within normal values, averaging (110.694).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
COO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

COO is expected to report earnings to fall 10.43% to $1.03 per share on February 26

Cooper Companies (The) COO Stock Earnings Reports
Q1'26
Est.
$1.03
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.03
Q1'25
Est.
$0.92
The last earnings report on December 04 showed earnings per share of $1.15, beating the estimate of $1.11. With 362.52K shares outstanding, the current market capitalization sits at 15.81B.
A.I.Advisor
published Dividends

COO paid dividends on August 11, 2023

Cooper Companies (The) COO Stock Dividends
А dividend of $0.03 per share was paid with a record date of August 11, 2023, and an ex-dividend date of July 26, 2023. Read more...
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6101 Bollinger Canyon Road
Phone
+1 925 460-3600
Employees
15000
Web
https://www.coopercos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PRCS27.410.20
+0.74%
Parnassus Core Select ETF
EVYM50.150.18
+0.35%
Eaton Vance High Income Municipal ETF
FXA68.81-0.14
-0.20%
Invesco CcyShrs® Australian Dllr Trust
BTAL14.09-0.13
-0.91%
AGF U.S. Market Neutral Anti-Beta
ASHR33.08-0.36
-1.08%
Xtrackers Harvest CSI 300 China A ETF

COO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with ALC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
-0.90%
ALC - COO
52%
Loosely correlated
-1.98%
A - COO
50%
Loosely correlated
+1.15%
RGEN - COO
47%
Loosely correlated
+1.17%
DHR - COO
46%
Loosely correlated
+2.07%
SYK - COO
44%
Loosely correlated
-0.38%
More

Groups containing COO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
-0.90%
Pharmaceuticals: Other
industry (107 stocks)
55%
Loosely correlated
-0.39%
Pharmaceuticals
industry (380 stocks)
46%
Loosely correlated
+27.23%